Clinical Trials | November 11, 2021
LifeCell Diagnostics expands newborn screening portfolio
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
Tezepelumab has been granted Orphan Drug Designation (ODD) in the US by the U.S. Food and Drug Administration (FDA) for the treatment of eosinophilic esophagitis (EoE)
It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
Extension of hypericin orphan designation beyond cutaneous T-cell lymphoma
The drug is also intended for the treatment of glioblastoma multiforme
Subscribe To Our Newsletter & Stay Updated
